Drug profile · INN
quinapril
ACQUIN
quinapril (ACQUIN) is a angiotensin-converting enzyme inhibitor. Associated with Lacuna Pharma Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — quinapril
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.81
Quick answer
quinapril (ACQUIN) is a angiotensin-converting enzyme inhibitor. Associated with Lacuna Pharma Pty Ltd.
Key facts
INN quinapril
Brand ACQUIN
Mechanism Angiotensin-converting enzyme inhibitor
Originator Lacuna Pharma Pty Ltd
Mechanism of action
Angiotensin-converting enzyme inhibitor
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Frequently asked questions
What is quinapril?
quinapril (ACQUIN) is a angiotensin-converting enzyme inhibitor. Associated with Lacuna Pharma Pty Ltd.
What is the brand name for quinapril?
ACQUIN is a marketed brand name for quinapril. Check FDA Drugs@FDA for the current US label holder and prescribing information.